Let me start with something that I think about constantly, both as a clinician and as someone who has personally white-knuckled her way through more extreme diets than I care to admit: losing weight is not the same thing as getting healthier. I know that sounds counterintuitive, especially if you have spent years being told that the number on the scale is the whole story. But it is not. Not even close.
If you are reading this, there is a good chance you are either currently using a GLP-1 receptor agonist or considering one. And I want you to know something right up front: these therapies can be genuinely transformative. The STEP 1 trial demonstrated that participants using a GLP-1 receptor agonist achieved a mean weight loss of approximately 14.9% of their body weight over 68 weeks, which is remarkable by any clinical standard (Wilding et al. 989). That kind of result used to be reserved for surgical intervention. So yes, these tools are powerful.
But here is the part that does not get enough airtime: not all weight loss is created equal. When we lose weight, we are not exclusively burning fat. We are also losing lean body mass, which includes our skeletal muscle. And muscle, my friends, is not just about aesthetics or how your arms look in a tank top (though there is nothing wrong with caring about that, too). Muscle is metabolically active tissue. It is what keeps your resting metabolism humming. It supports your joints, protects your bones, regulates your blood sugar, and (speaking from my cardiology hat) plays a critical role in cardiovascular health.
Research published in Diabetes, Obesity and Metabolism found that lean body mass can account for anywhere from 25% to as much as 40% of total weight lost during GLP-1 receptor agonist therapy (Neeland et al. 1). And a review in Circulation reported that in certain trials, lean mass loss reached up to 40% of total weight lost with semaglutide specifically (Linge et al.). That is not an insignificant number. That is your body potentially cannibalizing the very tissue you need most for long-term metabolic health.
So what do we do about it? We get strategic. And one of the simplest, most evidence-backed strategies available is whey protein supplementation.
Why Muscle Loss Happens During Weight Loss (and Why GLP-1s Are Not the Villain)
Before we go any further, I want to be really clear about something: GLP-1 receptor agonists are not uniquely terrible for muscle mass. Lean body mass loss occurs with virtually every form of significant weight reduction, including calorie-restricted diets and bariatric surgery. A systematic review by Chaston et al. established decades ago that meaningful weight loss universally involves some reduction in fat-free mass (Chaston et al. 743). The issue is not the therapy itself. The issue is that we are finally achieving the kind of significant weight loss that makes body composition a real clinical conversation.
Researchers at Mass General Brigham have emphasized this point clearly, noting that the data does not show GLP-1 analogs cause a uniquely high degree of lean body mass loss compared to other weight loss approaches (Apovian et al.). What is different now is the scale of weight reduction. When you are losing 15% to 20% of your body weight, the absolute amount of lean tissue at risk is simply greater. And that is where intentional nutritional strategies become non-negotiable.
Here is what happens at the cellular level when you are in a calorie deficit (which is exactly what GLP-1 therapy creates by suppressing appetite and slowing gastric emptying): the rate of muscle protein synthesis, or MPS, drops. Your body is getting fewer calories and fewer amino acids from food, so it downregulates the energy-expensive process of building and maintaining muscle. A study from McMaster University found that even a short-term energy deficit can reduce postprandial myofibrillar protein synthesis by roughly 27% (Areta et al. E989). That is your body essentially saying, "We do not have the resources to maintain all this muscle right now." And if you are not deliberately pushing back against that signal with adequate protein and resistance training, muscle loss is the predictable outcome.
Enter Whey Protein: Why It Is Uniquely Suited for This Job
Not all protein sources are created equal when it comes to preserving muscle during a calorie deficit. And this is where whey protein genuinely shines.
A landmark clinical trial published in The Journal of Nutrition by Hector et al. at McMaster University directly compared whey protein, soy protein, and a carbohydrate control in overweight and obese adults during a 14-day calorie-restricted diet. The results were striking. The rate of myofibrillar protein synthesis declined by only 9% in the whey protein group, compared to a 28% decline with soy protein and a 31% decline with the carbohydrate control (Hector et al. 246). Let that sink in. Whey protein preserved the muscle-building machinery at nearly three times the efficiency of soy during the exact metabolic state that GLP-1 therapy creates.
Why is whey so effective? It comes down to amino acid composition. Whey protein is one of the richest natural sources of leucine, a branched-chain amino acid that acts as a primary trigger for muscle protein synthesis. Think of leucine as the ignition switch. You can have all the building materials in the world, but without turning the key, the construction crew does not start working. Whey delivers a rapid, robust spike in plasma leucine levels that other protein sources simply cannot match at equivalent doses.
A more recent dose-response study by McKenna et al. examined whey protein specifically in overweight postmenopausal women after five days of energy restriction. The researchers found that a 35-gram dose of whey protein was sufficient to stimulate a maximal acute muscle protein synthesis response, and that increasing to 60 grams offered no additional benefit (McKenna et al.). This is incredibly practical information, especially for people on GLP-1 therapy who may be eating less overall and need to make every gram of protein count.
There is also the satiety factor, which I think is underappreciated. When your appetite is already suppressed by a GLP-1 receptor agonist, the last thing you want is to feel like you are force-feeding yourself. Whey protein is relatively easy to consume in liquid form (a shake, blended into a smoothie, stirred into oatmeal) and it is rapidly digested. For my patients who tell me they just cannot eat a full meal, a whey protein shake can be the difference between meeting their protein target and falling dangerously short.
How Much Protein Do You Actually Need?
This is the million-dollar question, and the answer has evolved significantly in recent years. The standard Recommended Dietary Allowance (RDA) for protein is 0.8 grams per kilogram of body weight per day, but that number was designed to prevent deficiency in generally healthy, weight-stable adults. It was never intended as a target for someone actively losing weight on a GLP-1 receptor agonist.
A 2025 joint advisory issued by the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society recommended that individuals undergoing active weight reduction aim for 1.2 to 1.6 grams of protein per kilogram of body weight daily, with some experts suggesting that setting an absolute target of 80 to 120 grams per day may enhance adherence while ensuring adequate intake (Mozaffarian et al.). The advisory also emphasized that increased protein intake alone is likely insufficient to preserve muscle mass without structured resistance or strength training.
A cross-sectional study published in Frontiers in Nutrition examined nutrient intake in people actively using GLP-1 receptor agonists and found that while 75% of participants reported eating more protein since starting therapy, only 43% actually consumed at least 1.2 grams per kilogram per day (Sanchez et al.). That gap between intention and execution is exactly why supplementation matters. When your appetite is telling you to stop eating but your muscles are screaming for amino acids, whey protein bridges that gap efficiently.
And let me be honest with you: I have been in that exact position. After years of competing and then years of recovering from the metabolic fallout of competition prep, I know what it feels like to not want to eat but to know that your body needs fuel. Whey protein was one of the tools that helped me stay consistent without the psychological burden of forcing down another plate of chicken. It is not glamorous, but it works.
The Synergy of Whey Protein and Resistance Training
I would be doing you a disservice if I talked about whey protein without talking about resistance training, because here is the reality: protein provides the raw materials, but it is resistance exercise that sends the signal to your body that it needs to keep (and build) muscle. Without that signal, even adequate protein intake may not fully prevent lean mass loss during a significant calorie deficit.
A randomized trial by Longland et al. published in The American Journal of Clinical Nutrition demonstrated this beautifully. Young men in a 40% calorie deficit who consumed 2.4 grams of protein per kilogram per day (using whey protein supplementation post-exercise) while performing resistance training and high-intensity interval training six days per week actually gained lean body mass while losing fat. The higher-protein group gained an average of 1.2 kilograms of lean mass while losing 4.8 kilograms of fat over four weeks (Longland et al. 738). That is not just preservation. That is improvement in body composition during an aggressive calorie deficit.
For those of us who are not 20-something men training six days a week (which, for the record, I am very much not), the takeaway is still encouraging. A 2025 case series published in Obesity examined three patients who prioritized resistance training three to five days per week alongside higher protein intakes while using GLP-1 receptor agonist or dual GIP/GLP-1 receptor agonist therapy. The results ranged from minimal lean soft tissue loss of 6.9% (compared to 33% total weight loss) to actual gains in lean tissue of up to 5.8%, even while losing over 13% of total body weight (Helms et al.). These are real people, not lab animals, getting real-world results with the combination of targeted nutrition and exercise.
The practical message? Aim for at least two to three sessions of resistance training per week targeting all major muscle groups. Consume 25 to 40 grams of whey protein within an hour or two of your training session. And do not skip the other meals. Distributing your protein intake across three to four eating occasions throughout the day (rather than loading it all at dinner) maximizes the muscle protein synthesis response at each meal.
Practical Tips for Making Whey Protein Work for You
I am a clinician, but I am also a realist. I know that advice is only useful if it is actually doable. So here is what I tell my patients (and what I practice myself):
Start your day with protein. If you can tolerate it, a whey protein shake in the morning sets the tone for the rest of the day. Blend it with some frozen fruit, a handful of spinach, and a tablespoon of nut butter, and you have a nutrient-dense meal that takes three minutes to make.
Prioritize protein at every eating occasion. Even if your appetite is suppressed and you are only eating small amounts, make sure protein is the first thing on your plate (or in your glass). Eat your protein before your carbohydrates and fats. This is a simple behavioral shift that can make an outsized difference in total daily intake.
Choose a high-quality whey protein isolate. Look for products that have been third-party tested, contain at least 20 to 25 grams of protein per serving with minimal added sugars, and list whey protein isolate (not concentrate) as the first ingredient. Isolate is more refined, higher in protein per gram, and generally better tolerated by people with lactose sensitivity.
Do not rely on protein alone. I cannot say this enough: whey protein is a tool, not a magic bullet. It works best in the context of an overall dietary pattern that includes whole foods, adequate fiber, micronutrient diversity, and regular physical activity. If you are on a GLP-1 receptor agonist and not doing any form of resistance training, adding protein alone is probably not going to fully protect your muscle mass. The research is unambiguous on this point (Mozaffarian et al.).
Talk to your healthcare team. If you are losing weight rapidly (more than 1 to 2 pounds per week consistently), if you are feeling noticeably weaker, or if you are struggling to consume adequate nutrition, please bring this up with your provider. Body composition monitoring through methods like DXA scanning can provide objective data about what is happening beneath the surface, and your nutrition and exercise plan can be adjusted accordingly.
The Bottom Line
GLP-1 receptor agonist therapy is one of the most significant advances in weight management that I have seen in my clinical career. But the goal was never just to make the number on the scale go down. The goal is to help you become healthier, stronger, and more resilient. That means we have to pay attention to what we are losing, not just how much.
Whey protein is not a miracle supplement. It is a practical, evidence-based nutritional tool that can help preserve the muscle protein synthesis your body needs to maintain lean mass during a calorie deficit. When combined with resistance training and an overall balanced approach to nutrition, it can meaningfully shift the composition of your weight loss toward fat and away from muscle.
You deserve a weight loss journey that leaves you stronger, not weaker. And I believe, based on both the research and my own lived experience, that whey protein can play a meaningful role in making that happen.
Your body is doing incredible work right now. Let’s make sure we are giving it what it needs to do that work well.
About the Author
Erin Riley, PA-C, RD, MS is a board-certified physician assistant (Yale School of Medicine), registered dietitian, and holds a master’s degree in Nutrition and Human Performance. She currently practices in cardiology at Atlantic Cardiology LLC and has extensive clinical experience in family medicine, primary care, and eating disorder treatment at institutions including the University Medical Center of Princeton at Plainsboro, GenPsych PC, and Princeton University, where she served as Clinical and Sports Dietitian. A former NCAA Division I gymnast at the University of Missouri and former IFBB Pro Fitness Competitor who competed at the Olympia and Arnold Classic, Erin brings a unique perspective that bridges elite athletic performance, clinical nutrition, and compassionate patient care. Her writing focuses on evidence-based approaches to nutrition, fitness, and metabolic health that honor both the science and the lived human experience of navigating body composition, weight management, and long-term wellness.
Works Cited
Areta, José L., et al. “Reduced Resting Skeletal Muscle Protein Synthesis Is Rescued by Resistance Exercise and Protein Ingestion Following Short-Term Energy Deficit.” American Journal of Physiology-Endocrinology and Metabolism, vol. 306, no. 8, 2014, pp. E989–E997.
Chaston, T. B., et al. “Changes in Fat-Free Mass during Significant Weight Loss: A Systematic Review.” International Journal of Obesity, vol. 31, no. 5, 2007, pp. 743–750.
Hector, Amy J., et al. “Whey Protein Supplementation Preserves Postprandial Myofibrillar Protein Synthesis during Short-Term Energy Restriction in Overweight and Obese Adults.” The Journal of Nutrition, vol. 145, no. 2, 2015, pp. 246–252.
Helms, Eric R., et al. “Preservation of Lean Soft Tissue during Weight Loss Induced by GLP-1 and GLP-1/GIP Receptor Agonists: A Case Series.” Obesity, 2025.
Linge, Jennifer, et al. “Muscle Mass and Glucagon-Like Peptide-1 Receptor Agonists: Adaptive or Maladaptive Response to Weight Loss?” Circulation, 2024.
Longland, Thomas M., et al. “Higher Compared with Lower Dietary Protein during an Energy Deficit Combined with Intense Exercise Promotes Greater Lean Mass Gain and Fat Mass Loss: A Randomized Trial.” The American Journal of Clinical Nutrition, vol. 103, no. 3, 2016, pp. 738–746.
McKenna, Colleen F., et al. “Dose-Response of Myofibrillar Protein Synthesis to Ingested Whey Protein during Energy Restriction in Overweight Postmenopausal Women: A Randomized, Controlled Trial.” The Journal of Nutrition, vol. 153, no. 9, 2023, pp. 2568–2578.
Mozaffarian, Dariush, et al. “Nutritional Priorities to Support GLP-1 Therapy for Obesity: A Joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society.” Obesity, 2025.
Neeland, Ian J., et al. “Changes in Lean Body Mass with Glucagon-Like Peptide-1-Based Therapies and Mitigation Strategies.” Diabetes, Obesity and Metabolism, vol. 26, no. 8, 2024, pp. 1–16.
Sanchez, Leah, et al. “Investigating Nutrient Intake during Use of Glucagon-Like Peptide-1 Receptor Agonists: A Cross-Sectional Study.” Frontiers in Nutrition, vol. 12, 2025.
Wilding, John P. H., et al. “Once-Weekly Semaglutide in Adults with Overweight or Obesity.” The New England Journal of Medicine, vol. 384, no. 11, 2021, pp. 989–1002.
